Search Results - "Sipambo, Nosisa"

Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa by Patten, Gabriela, Sipambo, Nosisa, Technau, Karl-Günter, Euvrard, Jonathan, Ford, Nathan, Davies, Mary-Ann

“…Among children in Southern Africa severe immune suppression (SIS) has declined, but most continue to initiate antiretroviral therapy (ART) with SIS. Using data…”
Get full text

Paediatric antiretroviral update by Sorour, Gillian, Sipambo, Nosisa, Archary, Moherndran

“…South Africa has lagged behind other countries in offering daily dosing of palatable, simple, well-tolerated and effective paediatric antiretroviral…”
Get full text

Southern African HIV Clinicians Society guideline on the management of non-tuberculous mycobacteria in people with HIV by Dawood, Halima, Richards, Lauren, Lutchminarain, Keeren, Parker, Arifa, Wattrus, Camilla, Sipambo, Nosisa, Nel, Jeremy, Manzini, Thandekile, Naidoo, Kogieleum

“…No Abstract required…”
Get full text

Optimised paediatric antiretroviral treatment to achieve the 95-95-95 goals by Archary, Moherndran, van Zyl, Riana, Sipambo, Nosisa, Sorour, Gillian

“…While the progress towards reaching the UNAIDS 95-95-95 targets in South African adults seems promising, the progress in the paediatric population is lagging…”
Get full text

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission by Nyakato, Patience, Davies, Mary-Ann, Technau, Karl-Gunter, Fatti, Geoffrey, Rabie, Helena, Tanser, Frank, Boulle, Andrew, Wood, Robin, Eley, Brian, Sawry, Shobna, Giddy, Janet, Sipambo, Nosisa, Kuhn, Louise, Fairlie, Lee

“…Efavirenz-based first-line regimens have been widely used for children ≥3 years of age starting antiretroviral therapy, despite possible resistance with prior…”
Get full text

Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa by Sengayi, Mazvita, Dwane, Ntabozuko, Marinda, Edmore, Sipambo, Nosisa, Fairlie, Lee, Moultrie, Harry

“…Background : Ninety percent of the world's 2.1 million HIV-infected children live in sub-Saharan Africa, and 2.5% of South African children live with HIV. As…”
Get full text

Ongoing high prevalence of severe immune suppression among children in South Africa by Patten, Gabriela, Sipambo, Nosisa, Technau, Karl-Günter, Euvrard, Jonathan, Ford, Nathan, Davies, Mary-Ann

Get full text

Field Evaluation of Performance of Alere and Cepheid Qualitative HIV Assays for Pediatric Point-of-Care Testing in an Academic Hospital in Soweto, South Africa by Murray, Tanya Y, Sherman, Gayle G, Nakwa, Firdose, MacLeod, William B, Sipambo, Nosisa, Velaphi, Sithembiso, Carmona, Sergio

“…Point-of-care (POC) technologies for HIV diagnosis in infants have the potential to overcome logistical challenges that delay treatment initiation and prevent…”
Get full text

Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts by de Waal, Reneé, Rabie, Helena, Technau, Karl-Günter, Eley, Brian, Sipambo, Nosisa, Cotton, Mark, Boulle, Andrew, Wood, Robin, Tanser, Frank, Fatti, Geoffrey, Egger, Matthias, Davies, Mary-Ann

“…WHO guidelines recommend abacavir in first-line antiretroviral treatment for children and neonates. However, there is no approved dose <3 months of age, and…”
Get more information

Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics by Zaniewski, Elizabeth, Skrivankova, Veronika Whitesell, Brazier, Ellen, Avihingsanon, Anchalee, Cardoso, Sandra Wagner, Cesar, Carina, Chenal, Henri, Crabtree-Ramírez, Brenda E, Ditangco, Rossana A, Ebasone, Peter Vanes, Eley, Brian, Euvrard, Jonathan George, Fatti, Geoffrey, Huwa, Jacqueline Madalitso, Lelo, Patricia, Machado, Daisy Maria, Messou, Eugene Kouassi, Minga, Albert Kla, Muleebwa, Joseph, Mundhe, Sanjay, Murenzi, Gad, Muyindike, Winnie R, Nsonde, Dominique Mahambou, Obatsa, Sarah M, Odhiambo, Joseph, Prozesky, Hans Walter, Rungmaitree, Supattra, Semeere, Aggrey Semwendero, Seydi, Moussa, Sipambo, Nosisa, Sudjaritruk, Tavitiya, Technau, Karl-Günter, Tiendrebeogo, Thierry, Twizere, Christelle, Ballif, Marie

“…We studied the transition to dolutegravir-containing antiretroviral therapy (ART) at HIV treatment clinics within the International epidemiology Databases to…”
Get full text

Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10–14 years) in South Africa by Nyakato, Patience, Schomaker, Michael, Sipambo, Nosisa, Technau, Karl-Günter, Fatti, Geoffrey, Rabie, Helena, Tanser, Frank, Eley, Brian, Euvrard, Jonathan, Wood, Robin, Tsondai, Priscilla R., Yiannoutsos, Constantin T., Cornell, Morna, Davies, Mary-Ann

Get full text

Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10–14 years) in South Africa by Nyakato, Patience, Schomaker, Michael, Sipambo, Nosisa, Technau, Karl-Günter, Fatti, Geoffrey, Rabie, Helena, Tanser, Frank, Eley, Brian, Euvrard, Jonathan, Wood, Robin, Tsondai, Priscilla R., Yiannoutsos, Constantin T., Cornell, Morna, Davies, Mary-Ann

“…Adolescents living with perinatally acquired HIV (ALPHIV) on antiretroviral therapy (ART) have been noted to have poorer adherence, retention and virologic…”
Get full text

Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa by Zaniewski, Elizabeth, Dao Ostinelli, Cam H, Chammartin, Frédérique, Maxwell, Nicola, Davies, Mary‐Ann, Euvrard, Jonathan, Dijk, Janneke, Bosomprah, Samuel, Phiri, Sam, Tanser, Frank, Sipambo, Nosisa, Muhairwe, Josephine, Fatti, Geoffrey, Prozesky, Hans, Wood, Robin, Ford, Nathan, Fox, Matthew P, Egger, Matthias

“…Introduction The World Health Organization (WHO) recommends a CD4 cell count before starting antiretroviral therapy (ART) to detect advanced HIV disease, and…”
Get full text

The Etiology of Pneumonia in HIV-1-infected South African Children in the Era of Antiretroviral Treatment: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study by Moore, David P., Baillie, Vicky L., Mudau, Azwifarwi, Wadula, Jeannette, Adams, Tanja, Mangera, Shafeeka, Verwey, Charl, Sipambo, Nosisa, Liberty, Afaaf, Prosperi, Christine, Higdon, Melissa M., Haddix, Meredith, Hammitt, Laura L., Feikin, Daniel R., O’Brien, Katherine L., Deloria Knoll, Maria, Murdoch, David R., Simões, Eric A. F., Madhi, Shabir A.

“…HIV-1 infection predisposes to an increased burden of pneumonia caused by community-acquired and opportunistic pathogens. Within the context of the Pneumonia…”
Get full text

Paediatric antiretroviral update by Sorour, Gillian, Sipambo, Nosisa, Archary, Moherndran

Get full text

Virologic non‐suppression and early loss to follow up among pregnant and non‐pregnant adolescents aged 15–19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study by Nyakato, Patience, Schomaker, Michael, Fatti, Geoffrey, Tanser, Frank, Euvrard, Jonathan, Sipambo, Nosisa, Fox, Matthew P., Haas, Andreas D., Yiannoutsos, Constantin T., Davies, Mary‐Ann, Cornell, Morna

“…Introduction Older adolescents aged 15–19 years continue to have high rates of loss to follow up (LTFU), and high rates of virologic non‐suppression (VNS)…”
Get full text

Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions by Jallow, Sabelle, Madhi, Shabir A., Madimabe, Richard, Sipambo, Nosisa, Violari, Avy, Kala, Udai, Petersen, Karen, Naidoo, Sanushka, Verwey, Charl, Moore, David P., Nunes, Marta C.

“…•Children with chronic disease are at risk of pneumococcal disease.•PCV13 immunogenicity data for children with chronic disease is scarce.•One PCV13 dose…”
Get full text

What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies by Patten, Gabriela, Schomaker, Michael, Davies, Mary-Ann, Rabie, Helena, van Zyl, Gert, Technau, Karl, Eley, Brian, Boulle, Andrew, Van Dyke, Russell B, Patel, Kunjal, Sipambo, Nosisa, Wood, Robin, Tanser, Frank, Giddy, Janet, Cotton, Mark, Nuttall, James, Essack, Gadija, Karalius, Brad, Seage, George, Sawry, Shobna, Egger, Matthias, Fairlie, Lee

“…BACKGROUND:Managing virologic failure (VF) in HIV-infected children is especially difficult in resource-limited settings, given limited availability of…”
Get full text

Outcomes in treatment with darunavir/ritonavir in ART-experienced paediatric patients by Kindra, Gurpreet, Sipambo, Nosisa, Moultrie, Harry, Fairlie, Lee

Get full text

What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies by Patten, Gabriela, Schomaker, Michael, Davies, Mary-Ann, Rabie, Helena, van Zyl, Gert, Technau, Karl, Eley, Brian, Boulle, Andrew, Van Dyke, Russell B, Patel, Kunjal, Sipambo, Nosisa, Wood, Robin, Tanser, Frank, Giddy, Janet, Cotton, Mark, Nuttall, James, Essack, Gadija, Karalius, Brad, Seage, George, Sawry, Shobna, Egger, Matthias, Fairlie, Lee

“…Managing virologic failure (VF) in HIV-infected children is especially difficult in resource-limited settings, given limited availability of alternative drugs,…”
Get full text